The Impacts of Trichomonas vaginalis on the Quality of Life in Women

Main Article Content

Samuel Tamunoiyowuna Cockeye Brown
Usman Ikrimah Mohammed
Eze Emmanuel Onyemaechi
Yusuf Precious Wama

Abstract

Trichomoniasis is a significant global health concern, particularly affecting women of reproductive age. In many public health settings, diagnosis is commonly based solely on clinical signs and symptoms. However, this approach can lead to misdiagnosis, as trichomoniasis shares similar clinical presentations with other vaginal infections. Caused by the protozoan Trichomonas vaginalis, trichomoniasis is one of the most prevalent non-viral sexually transmitted infections (STIs), often linked to reproductive tract infections, infertility, cervical cancer, premature births, and low birth weight in newborns. According to the World Health Organization, approximately 276.4 million cases were reported in 2008, with nearly 90% occurring in resource-limited settings. The global prevalence among women is estimated at 8.1%, making it more common than Chlamydia trachomatis, Neisseria gonorrhoeae, and syphilis combined. Various studies have identified key risk factors associated with T. vaginalis infection, particularly among adolescent girls and women attending STI clinics. These include unprotected sexual intercourse, multiple sexual partners, a longer history of sexual activity, previous STIs, and higher prevalence among Black populations. Beyond its physical health implications, trichomoniasis significantly impacts women’s quality of life, affecting sexual function, reproductive outcomes, mental health, and social well-being. The stigma surrounding STIs, coupled with the often asymptomatic nature of trichomoniasis, contributes to delayed diagnosis, untreated infections, and continued community transmission. Effective prevention and control require comprehensive strategies including safe sex practices, regular screening, early diagnosis, partner notification, and timely treatment. Addressing the broader social and psychological dimensions of the disease is essential for improving health outcomes and reducing the burden of trichomoniasis on women’s health globally.

Downloads

Download data is not yet available.

Scopus Citation Data

Data source Crossref
0
citations
Check Secondary Documents in Scopus
Open this article in Scopus, then check the Secondary documents tab. Use Manual Citation Fallback only for counts you have verified manually.
Open in Scopus
Similar Scopus Articles
Scopus
  1. Xu W. (2027)
    Endoscopic Thrombin Injection for Gastric Variceal Bleeding: A Systematic Review and Meta-Analysis of Observational and Trial Data
    Den Open, 7(1)
  2. Sato K. (2027)
    Optimal Stenting Strategy During Chemotherapy: Impact of Time to First Reintervention on Survival in Malignant Hilar Biliary Obstruction
    Den Open, 7(1)
  3. Bhagyasree M.R. (2027)
    CONSUMER HEALTH ENTOMOLOGY-A FORTIORI INDUSTRIAL SCIENCE OF EMERGING PUBLIC HEALTH SIGNIFICANCE, WITH EMPHASIS ON ITS COMMERCIAL, BEHAVIOURAL AND SOCIAL CONSIDERATIONS
    Indian Journal of Entomology, 89(1), 122-127

Article Details

How to Cite
Brown, S. T. C., Mohammed, U. I., Onyemaechi, E. E., & Wama, Y. P. (2025). The Impacts of Trichomonas vaginalis on the Quality of Life in Women. Kwaghe International Journal of Sciences and Technology, 2(2), 295-334. https://doi.org/10.58578/kijst.v2i2.6962

Explore Our Journals
Find the most suitable journal for your research. If this journal does not fully align with the scope of your manuscript, we invite you to explore our wider portfolio of journals covering diverse fields of study. Please select one of the journals below to identify the most appropriate publication platform for your work.

Most read articles by the same author(s)

1 2 > >>